ISMP IV push safety gap analysis survey

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

1 post / 0 new
Log in or register to post comments
Wed, 05/08/2019 - 08:00
#1
Andrea Gimpel-B...
Andrea Gimpel-Blanchard's picture
Offline
Last seen: 7 months 3 days ago
Joined: 01/26/2018 - 09:12
ISMP IV push safety gap analysis survey

Our organization completed the ISMP IV push safety gap analysis survey. Our improvement opportunities were to:
1. clearly define who has privileges to perform IV push medication preparation and administration
2. define in policy the difference between IV push and a bolus medication

How does your organization define the privileges and IVP versus a bolus?

Thank you very much,
Andrea Gimpel-Blanchard, PharmD
Director of Pharmacy
MaineGeneral Medical Center
Augusta, ME 04330

Top